C M Svahn

1.7k total citations · 1 hit paper
13 papers, 1.5k citations indexed

About

C M Svahn is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, C M Svahn has authored 13 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Cell Biology and 3 papers in Organic Chemistry. Recurrent topics in C M Svahn's work include Proteoglycans and glycosaminoglycans research (12 papers), Fibroblast Growth Factor Research (6 papers) and Glycosylation and Glycoproteins Research (3 papers). C M Svahn is often cited by papers focused on Proteoglycans and glycosaminoglycans research (12 papers), Fibroblast Growth Factor Research (6 papers) and Glycosylation and Glycoproteins Research (3 papers). C M Svahn collaborates with scholars based in United States, Israel and Hungary. C M Svahn's co-authors include David M. Ornitz, Ehud Levi, John G. Flanagan, Philip Leder, Avner Yayon, Marianne Nilsson, Jacob Westman, Shay Söker, Gera Neufeld and Israël Vlodavsky and has published in prestigious journals such as Science, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

C M Svahn

13 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells.

1992 541 citations David M. Ornitz, Avner Yayon et al. Molecular and Cellular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C M Svahn United States	12	1.2k	954	212	143	139	13	1.5k
Carl M. Svahn United States	10	864 0.7×	689 0.7×	155 0.7×	146 1.0×	66 0.5×	11	1.2k
Orit Goldshmidt Israel	16	822 0.7×	875 0.9×	62 0.3×	128 0.9×	133 1.0×	21	1.2k
Katarina Holmborn Sweden	13	803 0.7×	657 0.7×	141 0.7×	85 0.6×	100 0.7×	14	1.0k
Svetlana Gingis‐Velitski Israel	19	917 0.8×	742 0.8×	74 0.3×	175 1.2×	105 0.8×	25	1.3k
Riikka Kärnä Finland	20	727 0.6×	689 0.7×	83 0.4×	178 1.2×	74 0.5×	26	1.1k
Janet Andres United States	14	1.4k 1.2×	428 0.4×	199 0.9×	246 1.7×	25 0.2×	15	1.9k
Sylvain D. Vallet France	14	547 0.5×	347 0.4×	108 0.5×	175 1.2×	65 0.5×	19	1.1k
Jo Ann Buczek‐Thomas United States	17	407 0.4×	332 0.3×	93 0.4×	99 0.7×	56 0.4×	31	791
Anne Kultti Finland	13	991 0.9×	901 0.9×	104 0.5×	315 2.2×	48 0.3×	15	2.0k
Wouter Korver United States	19	1.0k 0.9×	322 0.3×	176 0.8×	96 0.7×	23 0.2×	26	1.6k

Countries citing papers authored by C M Svahn

Since Specialization

Citations

This map shows the geographic impact of C M Svahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C M Svahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C M Svahn more than expected).

Fields of papers citing papers by C M Svahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C M Svahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C M Svahn. The network helps show where C M Svahn may publish in the future.

Co-authorship network of co-authors of C M Svahn

This figure shows the co-authorship network connecting the top 25 collaborators of C M Svahn. A scholar is included among the top collaborators of C M Svahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C M Svahn. C M Svahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Ahmed, Tanveer, et al.. (1997). Inhibition of Antigen-Induced Acute Bronchoconstriction, Airway Hyperresponsiveness, and Mast Cell Degranulation by a Nonanticoagulant Heparin: Comparison With a Low Molecular Weight Heparin. American Journal of Respiratory and Critical Care Medicine. 155(6). 1848–1855. 40 indexed citations

Westman, Jacob, Marianne Nilsson, David M. Ornitz, & C M Svahn. (1995). Synthesis and Fibroblast Growth Factor Binding of Oligosaccharides Related to Heparin and Heparan Sulphate. Journal of Carbohydrate Chemistry. 14(1). 95–113. 13 indexed citations

Bitan, Menachem, Ehud Levi, Marc Wygoda, et al.. (1995). Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.. PubMed. 31(2-3). 106–18. 17 indexed citations

Ornitz, David M., Andrew B. Herr, Marianne Nilsson, et al.. (1995). FGF Binding and FGF Receptor Activation by Synthetic Heparan-Derived Di- and Trisaccharides. Science. 268(5209). 432–436. 234 indexed citations

Söker, Shay, et al.. (1994). Variations in the Size and Sulfation of Heparin Modulate the Effect of Heparin on the Binding of VEGF165 to Its Receptors. Biochemical and Biophysical Research Communications. 203(2). 1339–1347. 97 indexed citations

Aviezer, David, Michal Safran, C M Svahn, et al.. (1994). Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.. Journal of Biological Chemistry. 269(1). 114–121. 222 indexed citations

Reich‐Slotky, Ronit, et al.. (1994). Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor.. Journal of Biological Chemistry. 269(51). 32279–32285. 68 indexed citations

Nilsson, Marianne, C M Svahn, & Jacob Westman. (1993). Synthesis of the methyl glycosides of a tri- and a tetra-saccharide related to heparin and heparan sulphate. Carbohydrate Research. 246(1). 161–172. 36 indexed citations

Söker, Shay, C M Svahn, & Gera Neufeld. (1993). Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin.. Journal of Biological Chemistry. 268(11). 7685–7691. 100 indexed citations

10.

Nilsson, Marianne, Jacob Westman, & C M Svahn. (1993). Synthesis of Tri-And Tetrasaccharides Present in the Linkage Region of Heparin and Heparan Sulphate. Journal of Carbohydrate Chemistry. 12(1). 23–37. 24 indexed citations

11.

Svahn, C M, et al.. (1992). Inhibition of angiogenesis by heparin fragments in the presence of hydrocortisone. Carbohydrate Polymers. 18(1). 9–16. 3 indexed citations

12.

Ornitz, David M., Avner Yayon, John G. Flanagan, et al.. (1992). Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells.. Molecular and Cellular Biology. 12(1). 240–247. 541 indexed citations breakdown →

13.

Sudhalter, Judith, et al.. (1989). Importance of Size, Sulfation, and Anticoagulant Activity in the Potentiation of Acidic Fibroblast Growth Factor by Heparin. Journal of Biological Chemistry. 264(12). 6892–6897. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact